Results 1 to 10 of about 14,087 (142)

The Enigmatic Role of GBA2 in Controlling Locomotor Function [PDF]

open access: yesFrontiers in Molecular Neuroscience, 2017
The non-lysosomal glucosylceramidase GBA2 catalyzes the hydrolysis of glucosylceramide to glucose and ceramide. Loss of GBA2 function results in accumulation of glucosylceramide.
Dagmar Wachten, Wachten Dagmar
exaly   +6 more sources

Selective labelling of GBA2 in cells with fluorescent β-d-arabinofuranosyl cyclitol aziridines [PDF]

open access: yesChemical Science
Fluorescent β- d -arabinofuranosyl cyclitol aziridine activity-based probes potently and selectively label GBA2 both in vitro and in cellulo , allowing visualization of overexpressed GBA2 using fluorescent ...
Herman Overkleeft   +2 more
exaly   +6 more sources

Truncated mutants of beta-glucosidase 2 (GBA2) are localized in the mitochondrial matrix and cause mitochondrial fragmentation

open access: yesPLoS ONE, 2020
The enzyme β-glucosidase 2 (GBA2) is clinically relevant because it is targeted by the drug miglustat (Zavesca®) and because it is involved in inherited diseases.
Aarnoud Van Der Spoel
exaly   +5 more sources

Impact of Gba2 on neuronopathic Gaucher’s disease and α-synuclein accumulation in medaka (Oryzias latipes) [PDF]

open access: yesMolecular Brain, 2021
Homozygous mutations in the lysosomal glucocerebrosidase gene, GBA1, cause Gaucher’s disease (GD), while heterozygous mutations in GBA1 are a strong risk factor for Parkinson’s disease (PD), whose pathological hallmark is intraneuronal α-synuclein (asyn)
Etsuro Nakanishi   +10 more
doaj   +4 more sources

Associations between genetic variants in sphingolipid metabolism pathway genes and hepatitis B virus-related hepatocellular carcinoma survival [PDF]

open access: yesFrontiers in Oncology, 2023
BackgroundAlthough the sphingolipid metabolism pathway is known to play a significant role in tumor progression, there have been few studies on how genetic variants in the sphingolipid metabolism pathway genes affect the survival of patients with ...
Binbin Jiang   +16 more
doaj   +2 more sources

Carrier-Free Gambogic Acid Dimer Self-Assembly Nanomedicines for Rheumatoid Arthritis Treatment [PDF]

open access: yesInternational Journal of Nanomedicine, 2023
Yuling Liu,1,* Xin Nie,2,3,* Yihan Wu,2 Longfei Lin,1 Qian Liao,1 Jingjing Li,4 Simon Ming-Yuen Lee,3 Hui Li,1,5 Jinming Zhang2 1Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, People’s Republic of China ...
Liu Y   +8 more
doaj   +2 more sources

Current and Novel Aspects on the Non-lysosomal β-Glucosylceramidase GBA2 [PDF]

open access: yesNeurochemical Research, 2015
The non-lysosomal β-glucosylceramidase GBA2 (EC3.2.1.45, GH116) is ubiquitously expressed in various mammal tissues and cell types where it catalyzes the hydrolysis of glucosylceramide into glucose and ceramide. Although it has been known for many years that the central nervous system is the main site of GBA2 expression and activity, little information
Rosaria Bassi   +2 more
exaly   +5 more sources

A novel mutation in the GBA2 gene in a Japanese patient with SPG46: A case report

open access: yeseNeurologicalSci, 2020
Hereditary spastic paraplegia (HSP) is a neurodegenerative disorder characterized by pyramidal weakness and spasticity of the lower limbs. SPG46, one of autosomal recessive HSP, is clinically characterized by spasticity and pyramidal weakness of the ...
Keiko Nakamura-Shindo   +6 more
doaj   +3 more sources

Accumulation of glucosylceramide in the absence of the beta-glucosidase GBA2 alters cytoskeletal dynamics. [PDF]

open access: yesPLoS Genetics, 2015
Glycosphingolipids are key elements of cellular membranes, thereby, controlling a variety of cellular functions. Accumulation of the simple glycosphingolipid glucosylceramide results in life-threatening lipid storage-diseases or in male infertility.
Diana Raju   +13 more
doaj   +6 more sources

GBA2 Mutations Cause a Marinesco-Sjögren-Like Syndrome: Genetic and Biochemical Studies.

open access: yesPLoS ONE, 2017
BackgroundWith the advent new sequencing technologies, we now have the tools to understand the phenotypic diversity and the common occurrence of phenocopies.
Kristoffer Haugarvoll   +12 more
doaj   +5 more sources

Home - About - Disclaimer - Privacy